Drug intelligence / Profile preview

Shugan Qingre granules

Development stage
Unknown
Lead developer
Kunming Chinese Medicine Factory
Administration
Oral
01

Overview

Shugan Qingre granules (also known as Shu-gan-qing-re formula or SGQR) is a traditional Chinese medicine (TCM) patent formula developed by Beijing Anding Hospital of Capital Medical University for the treatment of generalized anxiety disorder (GAD). Tailored from classic TCM prescriptions such as Xiao-yao powder and Gan-mai-da-zao decoction, the formula is composed of ten herbal ingredients: Radix Paeoniae Alba, Radix Bupleuri, Angelica Sinensis, Radix Curcumae, Poria Cocos, Bulbus Lilii, Cortex Albiziae, Radix Glycyrrhizae, Triticum aestivum L., and Fructus Jujubae. It functions by smoothing liver qi and clearing inner heat, which corresponds to the TCM pattern of fire derived from stagnation of liver-qi. Shugan Qingre granules have been evaluated in clinical trials, including a Phase 4 study comparing its efficacy and safety to buspirone in adults with mild-to-moderate GAD, where it also demonstrated regulatory effects on peripheral blood inflammatory cytokines.

Other names
SGQR formulaShu-gan-qing-re formulaShu-gan-qing-re granulesShugan Qingre formulaShugan Qingre recipe疏肝清热方疏肝清热颗粒

Beyond the preview

Go deeper on Shugan Qingre granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shugan Qingre granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call